DE3569930D1 - Esters of tri- and tetrapeptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them - Google Patents

Esters of tri- and tetrapeptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them

Info

Publication number
DE3569930D1
DE3569930D1 DE8585402528T DE3569930T DE3569930D1 DE 3569930 D1 DE3569930 D1 DE 3569930D1 DE 8585402528 T DE8585402528 T DE 8585402528T DE 3569930 T DE3569930 T DE 3569930T DE 3569930 D1 DE3569930 D1 DE 3569930D1
Authority
DE
Germany
Prior art keywords
group
gastric secretion
tetrapeptides
tri
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585402528T
Other languages
English (en)
Inventor
Jean Martinez
Jean Pierre Bali
Richard Magous
Bertrand Castro
Henri Demarne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Centre National de la Recherche Scientifique CNRS
Original Assignee
Sanofi SA
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA, Centre National de la Recherche Scientifique CNRS filed Critical Sanofi SA
Application granted granted Critical
Publication of DE3569930D1 publication Critical patent/DE3569930D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8585402528T 1984-12-20 1985-12-18 Esters of tri- and tetrapeptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them Expired DE3569930D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8419545A FR2575164B1 (fr) 1984-12-20 1984-12-20 Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DE3569930D1 true DE3569930D1 (en) 1989-06-08

Family

ID=9310829

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585402528T Expired DE3569930D1 (en) 1984-12-20 1985-12-18 Esters of tri- and tetrapeptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them

Country Status (7)

Country Link
US (1) US4687759A (de)
EP (1) EP0187095B1 (de)
JP (1) JPS61197595A (de)
AT (1) ATE42750T1 (de)
CA (1) CA1275550C (de)
DE (1) DE3569930D1 (de)
FR (1) FR2575164B1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861510B1 (en) 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
US5023077A (en) * 1989-01-24 1991-06-11 Aphton Corporation Immunogenic compositions and methods for the treatment and prevention of gastric and duodenal ulcer disease
ES2063912T3 (es) * 1989-01-24 1995-01-16 Aphton Corp Composiciones inmunogenicas frente a peptidos de gastrina.
US20030068326A1 (en) * 1998-05-15 2003-04-10 Aphton Corporation Method for the treatment of gastroesophageal reflux disease
JP2002515458A (ja) * 1998-05-15 2002-05-28 アフトン・コーポレーシヨン 高ガストリン血症の予防および処置
US20030091574A1 (en) * 2001-03-23 2003-05-15 Gevas Philip C. Combination treatment of pancreatic cancer
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
AU2002326356A1 (en) * 2001-07-09 2003-01-29 Aphton Corporation Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
US6810583B2 (en) * 2001-08-07 2004-11-02 International Business Machines Corporation Coupling of conductive vias to complex power-signal substructures
WO2004088326A2 (en) * 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
CA2561405C (en) * 2004-03-29 2014-01-21 Receptor Biologix, Inc. Monoclonal antibodies to gastrin hormone
EP1794586B1 (de) 2004-09-22 2013-01-30 Cancer Advances, Inc., Monoklonale antikörper gegen progastrin
CA3066756A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042487A (en) * 1964-06-25 1966-09-14 Ici Ltd Polypeptide derivatives
US3875137A (en) * 1973-04-20 1975-04-01 Searle & Co N-Substituted aspactyl peptide amids
US4012367A (en) * 1976-02-05 1977-03-15 G. D. Searle & Co. Anti-ulcer polypeptides containing L-aspartic acid and intermediates thereto
HU175152B (hu) * 1976-12-30 1980-05-28 Richter Gedeon Vegyeszet Sposob poluchenija peptidov s gastrin-aktivnost'ju, soderzhahhikh amino-oksi-kisloty
FR2537971A1 (fr) * 1982-12-16 1984-06-22 Commissariat Energie Atomique Nouveaux derives peptidiques, leur procede de fabrication et leur utilisation pharmaceutique

Also Published As

Publication number Publication date
US4687759A (en) 1987-08-18
EP0187095A1 (de) 1986-07-09
EP0187095B1 (de) 1989-05-03
JPS61197595A (ja) 1986-09-01
ATE42750T1 (de) 1989-05-15
FR2575164B1 (fr) 1987-03-20
FR2575164A1 (fr) 1986-06-27
CA1275550C (en) 1990-10-23

Similar Documents

Publication Publication Date Title
DE3569930D1 (en) Esters of tri- and tetrapeptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
FI86192B (fi) Stereoselektiv foerfarande foer framstaellning av omaettad laktoner.
US5736520A (en) Peptidase inhibitors
IL67965A0 (en) Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt thereof,certain compounds derived from 3-hydroxybutanoic acid and their preparation
ES8402559A1 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
CZ325496A3 (en) Amino acid derivatives, process for preparing and pharmaceutical compositions containing thereof
MY102689A (en) 4-amino-3-carbonyl substituted quinolines
DE3166150D1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation
ES8406438A1 (es) Procedimiento para preparar nuevos derivados de aminoacidos triciclicos
IL67552A0 (en) Cyclic octapeptides,their preparation and pharmaceutical compositions containing them
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
HU896606D0 (en) Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof
JPH01502021A (ja) ラクタムプソイドジペプチドを有するレニン抑制物質
DE3571990D1 (en) Reduced peptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them
CA2129032A1 (en) Phenylalanine analogs of bombesin
DE3467581D1 (en) Gastric secretion inhibiting peptide derivatives, process for their preparation and medicines containing them
DK137085D0 (da) Fremgangsmaade og mellemprodukter til fremstilling af racematfattigepeptider
AU1779088A (en) Guanidine-related compounds comprising a tetraphenylborate ion, process for obtaining these compounds and use of the compounds in peptide synthesis
DE3062923D1 (en) Psycho-pharmacological peptides, process for their preparation and therapeutical compositions containing them
DE69324019T2 (de) Pyridinyl/quinolinyl-endgruppen enthaltende alkylamino-ethynyl-alanin-amindiol derivate zur behandlung von bluthochdruck
IT1270613B (it) Lattami biciclici come intermedi per la sintesi di peptidi biologicamente attivi
DE3564580D1 (en) Dipeptide compounds having pharmaceutical activity and compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee